Axonics (STU:0I3) Current Accrued Expense : €13.6 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Axonics Current Accrued Expense?

Axonics's Current Accrued Expense for the quarter that ended in Mar. 2024 was €13.6 Mil.

Axonics's quarterly Current Accrued Expense increased from Sep. 2023 (€5.6 Mil) to Dec. 2023 (€9.7 Mil) and increased from Dec. 2023 (€9.7 Mil) to Mar. 2024 (€13.6 Mil).

Axonics's annual Current Accrued Expense increased from Dec. 2021 (€4.8 Mil) to Dec. 2022 (€6.2 Mil) and increased from Dec. 2022 (€6.2 Mil) to Dec. 2023 (€9.7 Mil).

Axonics Current Accrued Expense Historical Data

The historical data trend for Axonics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axonics Current Accrued Expense Chart

Axonics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

1.96

5.49

4.81

6.16

9.65

Axonics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															6.20	5.14	5.59	9.65	13.57

Axonics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Axonics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Axonics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Axonics (STU:0I3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axonics Inc (STU:0I3) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

AXNX:USA 0I3:Germany

Address

26 Technology Drive, Irvine, CA, USA, 92618

Website

https://www.axonics.com

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.

Axonics (STU:0I3) Headlines

No Headlines